FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3038862602> ?p ?o ?g. }

• W3038862602 endingPage "1651" @default.
• W3038862602 startingPage "1639" @default.
• W3038862602 abstract "The cluster of differentiation 34 (CD34) family, which includes CD34, podocalyxin-like protein 1 (PODXL), and PODXL2, are type-I transmembrane sialomucins and markers of hematopoietic stem cells (HSCs) and vascular-associated tissues. CD34 family proteins are expressed by endothelial cells and hematopoietic precursors. PODXL is well known to be associated with invadopodia formation and to promote the epithelial-mesenchymal transition, tumor migration and invasion. PODXL expression was correlated with poor survival of cancer patients. However, the role of PODXL2 in cancer has been less fully explored. To reveal the novel role of PODXL2 in breast cancer, the present study evaluated PODXL2 levels in relation to clinical outcomes of cancer patients by performing a bioinformatics analysis using the Oncomine database, Kaplan-Meier plots, and the CCLE database. Empirical validation of bioinformatics predictions was conducted utilizing the short hairpin (sh)-RNA silencing method for PODXL2 in the BT474 invasive ductal breast carcinoma cell line. The bioinformatics analysis revealed that PODXL2 overexpression was correlated with poor survival of breast cancer patients, suggesting an oncogenic role of PODXL2 in breast carcinoma. In a validation experiment, knockdown of PODXL2 in BT474 cells slightly influenced cell proliferation, suppressed migration, and inhibited expressions of downstream molecules, including Ras-related C3 botulinum toxin substrate 1 (Rac1), phosphorylated (p)-Akt (S473), and p-paxillin (Y31) proteins. In addition, knockdown of PODXL2 reduced expression levels of cancer stem cell (CSC) markers, including Oct-4 and Nanog, and the breast CSC marker aldehyde dehydrogenase 1 (ALDH1). Collectively, our present study demonstrated that PODXL2 plays a crucial role in cancer development and could serve as a potential prognostic biomarker in breast cancer patients." @default.
• W3038862602 created "2020-07-10" @default.
• W3038862602 creator A5013087704 @default.
• W3038862602 creator A5022147831 @default.
• W3038862602 creator A5042211118 @default.
• W3038862602 creator A5045133452 @default.
• W3038862602 creator A5053895064 @default.
• W3038862602 creator A5058385055 @default.
• W3038862602 creator A5062833336 @default.
• W3038862602 creator A5067292877 @default.
• W3038862602 creator A5078382134 @default.
• W3038862602 creator A5079609169 @default.
• W3038862602 creator A5080880299 @default.
• W3038862602 creator A5085045723 @default.
• W3038862602 date "2020-01-01" @default.
• W3038862602 modified "2023-10-04" @default.
• W3038862602 title "PODXL2 maintains cellular stemness and promotes breast cancer development through the Rac1/Akt pathway" @default.
• W3038862602 cites W1550230214 @default.
• W3038862602 cites W1908864745 @default.
• W3038862602 cites W1968097173 @default.
• W3038862602 cites W1976402722 @default.
• W3038862602 cites W1977918192 @default.
• W3038862602 cites W1987047793 @default.
• W3038862602 cites W1987761802 @default.
• W3038862602 cites W1998248450 @default.
• W3038862602 cites W2000502676 @default.
• W3038862602 cites W2002730346 @default.
• W3038862602 cites W2005895632 @default.
• W3038862602 cites W2018103000 @default.
• W3038862602 cites W2027839585 @default.
• W3038862602 cites W2034119142 @default.
• W3038862602 cites W2043398720 @default.
• W3038862602 cites W2044545697 @default.
• W3038862602 cites W2045090755 @default.
• W3038862602 cites W2048209624 @default.
• W3038862602 cites W2048451191 @default.
• W3038862602 cites W2050196094 @default.
• W3038862602 cites W2054612304 @default.
• W3038862602 cites W2056598800 @default.
• W3038862602 cites W2067526101 @default.
• W3038862602 cites W2070544303 @default.
• W3038862602 cites W2082731988 @default.
• W3038862602 cites W2085212074 @default.
• W3038862602 cites W2087310747 @default.
• W3038862602 cites W2090982381 @default.
• W3038862602 cites W2096283457 @default.
• W3038862602 cites W2099755355 @default.
• W3038862602 cites W2107914050 @default.
• W3038862602 cites W2108426942 @default.
• W3038862602 cites W2110901703 @default.
• W3038862602 cites W2112965812 @default.
• W3038862602 cites W2112975932 @default.
• W3038862602 cites W2114299743 @default.
• W3038862602 cites W2114843025 @default.
• W3038862602 cites W2119777691 @default.
• W3038862602 cites W2121311695 @default.
• W3038862602 cites W2134254608 @default.
• W3038862602 cites W2149970852 @default.
• W3038862602 cites W2156856630 @default.
• W3038862602 cites W2157050292 @default.
• W3038862602 cites W2162371443 @default.
• W3038862602 cites W2183984262 @default.
• W3038862602 cites W2472719595 @default.
• W3038862602 cites W2502436186 @default.
• W3038862602 cites W2562042063 @default.
• W3038862602 cites W2595717913 @default.
• W3038862602 cites W2604854812 @default.
• W3038862602 cites W2749613778 @default.
• W3038862602 cites W2757783981 @default.
• W3038862602 cites W2770862488 @default.
• W3038862602 cites W2791140706 @default.
• W3038862602 cites W2791923388 @default.
• W3038862602 cites W2903708756 @default.
• W3038862602 cites W2922026743 @default.
• W3038862602 cites W2951601616 @default.
• W3038862602 cites W2975236857 @default.
• W3038862602 cites W2976729123 @default.
• W3038862602 cites W2988004824 @default.
• W3038862602 cites W2999417355 @default.
• W3038862602 cites W3008590180 @default.
• W3038862602 cites W604230466 @default.
• W3038862602 doi "https://doi.org/10.7150/ijms.46125" @default.
• W3038862602 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7359396" @default.
• W3038862602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32669966" @default.
• W3038862602 hasPublicationYear "2020" @default.
• W3038862602 type Work @default.
• W3038862602 sameAs 3038862602 @default.
• W3038862602 citedByCount "13" @default.
• W3038862602 countsByYear W30388626022020 @default.
• W3038862602 countsByYear W30388626022021 @default.
• W3038862602 countsByYear W30388626022022 @default.
• W3038862602 countsByYear W30388626022023 @default.
• W3038862602 crossrefType "journal-article" @default.
• W3038862602 hasAuthorship W3038862602A5013087704 @default.
• W3038862602 hasAuthorship W3038862602A5022147831 @default.
• W3038862602 hasAuthorship W3038862602A5042211118 @default.
• W3038862602 hasAuthorship W3038862602A5045133452 @default.
• W3038862602 hasAuthorship W3038862602A5053895064 @default.

• next